Target intelligence / Profile preview

Hemagglutinin Protein (Influenza A) (HA)

Target
HA
Molecular classification
Glycoprotein, Viral protein, Fusion protein, Surface antigen
01

Overview

Hemagglutinin (HA) is the most abundant glycoprotein on the surface of influenza A viruses. It is a class I viral fusion protein that plays a central role in both viral attachment to host cells and subsequent membrane fusion, enabling viral entry into the host cell cytoplasm. HA is also the primary antigen recognized by neutralizing antibodies, making it a major target for immune responses and vaccine development. It binds to sialic acid-containing receptors on host cells, initiating infection, and undergoes conformational changes in acidic environments to facilitate viral membrane fusion. Due to its critical role in infection, HA is a key target for antiviral drug development and vaccine design.

Other names
HA proteinInfluenza hemagglutininHA trimer
02

Mechanism of action

Inhibition of receptor binding; prevention of conformational changes required for membrane fusion

03

Biological functions

Receptor bindingMembrane fusionViral entryAntigen presentation
04

Disease associations

InfectionInfluenza A pathogenesis
05

Safety considerations

Antigenic drift leading to vaccine escapePotential for antibody-dependent enhancement (ADE)Off-target effects of fusion inhibitors
06

Interacting drugs

NA (drugs targeting HA are in development)

2 more in the full profile.

Beyond the preview

Go deeper on Hemagglutinin Protein (Influenza A) (HA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin Protein (Influenza A) (HA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call